1.92
                                            Precedente Chiudi:
              $1.50
            Aprire:
              $1.65
            Volume 24 ore:
                4.34M
            Relative Volume:
              3.33
            Capitalizzazione di mercato:
                $311.87M
            Reddito:
              $400.57M
            Utile/perdita netta:
              $9.21M
            Rapporto P/E:
              48.00
            EPS:
                0.04
            Flusso di cassa netto:
                $146.36M
            1 W Prestazione:
              +15.66%
            1M Prestazione:
              +46.56%
            6M Prestazione:
                +105.94%
            1 anno Prestazione:
              -51.39%
            Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Nome
                  
                      Ironwood Pharmaceuticals Inc
                    
                Settore
                  Telefono
                  
                      617-621-7722
                    
                Indirizzo
                  
                      100 SUMMER STREET, SUITE 2300, BOSTON, MA
                    
                Confronta IRWD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                IRWD
                            
                             Ironwood Pharmaceuticals Inc | 1.92 | 243.65M | 400.57M | 9.21M | 146.36M | 0.04 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione | 
|---|---|---|---|
| 2025-04-15 | Downgrade | Jefferies | Buy → Hold | 
| 2025-04-15 | Downgrade | Wells Fargo | Overweight → Equal Weight | 
| 2025-04-14 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform | 
| 2024-09-09 | Iniziato | Leerink Partners | Market Perform | 
| 2024-08-08 | Downgrade | CapitalOne | Overweight → Equal Weight | 
| 2024-01-17 | Iniziato | Craig Hallum | Buy | 
| 2023-12-14 | Iniziato | Wells Fargo | Overweight | 
| 2023-11-09 | Iniziato | Jefferies | Buy | 
| 2023-09-28 | Iniziato | JMP Securities | Mkt Outperform | 
| 2022-09-02 | Iniziato | CapitalOne | Overweight | 
| 2022-04-22 | Iniziato | Piper Sandler | Overweight | 
| 2020-09-30 | Downgrade | Wells Fargo | Overweight → Equal Weight | 
| 2020-06-17 | Iniziato | Northland Capital | Outperform | 
| 2019-07-10 | Ripresa | Credit Suisse | Neutral | 
| 2019-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight | 
| 2019-02-25 | Aggiornamento | H.C. Wainwright | Sell → Neutral | 
| 2019-01-24 | Aggiornamento | JP Morgan | Underweight → Neutral | 
| 2018-11-07 | Downgrade | Credit Suisse | Outperform → Neutral | 
| 2018-11-07 | Downgrade | JP Morgan | Neutral → Underweight | 
| 2018-07-23 | Iniziato | H.C. Wainwright | Sell | 
| 2018-05-09 | Downgrade | Morgan Stanley | Equal-Weight → Underweight | 
| 2018-01-05 | Downgrade | BofA/Merrill | Buy → Underperform | 
| 2017-12-06 | Downgrade | Mizuho | Buy → Neutral | 
| 2017-07-21 | Downgrade | JP Morgan | Overweight → Neutral | 
| 2017-05-03 | Iniziato | Wells Fargo | Outperform | 
| 2017-04-07 | Reiterato | Mizuho | Buy | 
| 2017-02-22 | Reiterato | Barclays | Equal Weight | 
| 2016-11-04 | Reiterato | Mizuho | Buy | 
| 2016-10-24 | Reiterato | Wedbush | Neutral | 
| 2016-10-10 | Reiterato | Mizuho | Buy | 
| 2016-09-27 | Reiterato | WallachBeth | Hold | 
                    Mostra tutto
                     
                  
                Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie
Ironwood Pharmaceuticals (IRWD) Surges 28% on Strong Linzess Sal - GuruFocus
Ironwood surges 28% as beneficiary of partner AbbVie's Linzess Q3 sales (IRWD:NASDAQ) - Seeking Alpha
Ironwood Pharmaceuticals (IRWD) Expected to Announce Earnings on Thursday - MarketBeat
Live market analysis of Ironwood Pharmaceuticals Inc.July 2025 Analyst Calls & Daily Oversold Stock Bounce Ideas - newser.com
Will Ironwood Pharmaceuticals Inc. bounce back from current supportJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Is it time to cut losses on Ironwood Pharmaceuticals Inc.July 2025 Action & Weekly Top Stock Performers List - newser.com
Will Ironwood Pharmaceuticals Inc. (I76) stock split increase liquidityWeekly Risk Report & Stock Market Timing Techniques - newser.com
Price momentum metrics for Ironwood Pharmaceuticals Inc. explained2025 Buyback Activity & Weekly Chart Analysis and Guides - newser.com
Quantitative breakdown of Ironwood Pharmaceuticals Inc. recent moveMarket Growth Report & Pattern Based Trade Signal System - newser.com
Pattern recognition hints at Ironwood Pharmaceuticals Inc. upsideGlobal Markets & Weekly Stock Breakout Alerts - newser.com
Can Ironwood Pharmaceuticals Inc. (I76) stock retain market dominanceJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
Will breakout in Ironwood Pharmaceuticals Inc. lead to full recoveryEarnings Overview Report & Growth Focused Entry Point Reports - newser.com
Will Ironwood Pharmaceuticals Inc. stock outperform tech sector in 2025Weekly Trend Report & AI Based Trade Execution Alerts - newser.com
Why Ironwood Pharmaceuticals Inc. stock is a must watch in 2025July 2025 Pullbacks & Safe Capital Growth Stock Tips - newser.com
What is the fair value of Ironwood Pharmaceuticals Inc. stock now2025 Price Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
Ironwood Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Will Ironwood Pharmaceuticals Inc. outperform the market2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Published on: 2025-10-28 05:42:32 - newser.com
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Hold" by Analysts - MarketBeat
How to use a screener to detect Ironwood Pharmaceuticals Inc. breakoutsGap Down & Free Long-Term Investment Growth Plans - newser.com
Will Ironwood Pharmaceuticals Inc. stock reach all time highs in 2025Earnings Trend Report & Safe Entry Trade Signal Reports - Fundação Cultural do Pará
Real time breakdown of Ironwood Pharmaceuticals Inc. stock performance2025 Sector Review & Proven Capital Preservation Methods - newser.com
Aug Macro: Will Ironwood Pharmaceuticals Inc. stock recover faster than market2025 Bull vs Bear & Low Risk High Reward Trade Ideas - Fundação Cultural do Pará
Ironwood Pharmaceuticals Inc Azioni (IRWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ironwood Pharmaceuticals Inc Azioni (IRWD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale | 
|---|---|---|---|---|---|---|---|
| John Minardo | Chief Legal Officer | Aug 11 '25 | Sale | 0.84 | 7,754 | 6,513 | 400,378 | 
| Martini Gregory S. | Chief Financial Officer | Aug 11 '25 | Sale | 0.84 | 1,265 | 1,063 | 182,545 | 
| Silver Ronald | Principal Accounting Officer | Aug 11 '25 | Sale | 0.84 | 2,846 | 2,391 | 276,809 | 
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):
                 
            
         
                     
                             Scarica l'app Stockscreener
                    Scarica l'app Stockscreener